31 Mar 2022 15:33
Â
31 March 2022
SourceBio International plc
("SourceBio", the "Company" or the "Group")
Â
Director/PDMR Shareholding
Â
SourceBio International plc ("the Company") has been notified that on 30 March 2022, Harwood Capital LLP transferred 94,743 ordinary shares of 0.15 pence each in the Company ("Ordinary Shares") to Limited Partners of Harwood Private Equity IV L.P. ("HPE4") in order to satisfy distributions, in the normal course of business.
Â
Christopher Mills, Non-Executive Director of the Company is Chief Executive of Harwood Capital LLP.
Â
Â
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
Â
1  | Details of the person discharging managerial responsibilities / person closely associated  | |||||||
a)  | Name   |  Harwood Capital LLP as investment manager | ||||||
2  | Reason for the notification  | |||||||
a)  | Position/status   | Christopher Mills is a non-executive director of the issuer and Chief Executive of the investment manager | ||||||
b)  | Initial notification /Amendment   | Initial Notification | ||||||
3  | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  | |||||||
a)  | Name   | SourceBio International Plc | ||||||
b) Â | LEI Â Â | 213800KY4C9WU7WBW518 Â | ||||||
4  | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted   | |||||||
a)  | Description of the financial instrument, type of instrument | Ordinary shares of £0.0015 each | ||||||
Identification code | GB00BKSB1674 Â | |||||||
 | ||||||||
b)  | Nature of the transaction   | Transfer of shares  | ||||||
c) | Price(s) and volume(s) | Â | Â Â
   |  | ||||
d)  | Aggregated information  Volume Price |  N/A - single transaction | ||||||
e)  | Date of the transaction   | 30 March 2022 | ||||||
f)  | Place of the transaction  | Off market  | ||||||
Â